HCV Burden and Barriers to Elimination in the Middle East
- PMID: 32015874
- PMCID: PMC6988416
- DOI: 10.1002/cld.897
HCV Burden and Barriers to Elimination in the Middle East
Figures
References
-
- Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2016;2:161‐176. - PubMed
-
- World Health Organization . Global Hepatitis Report, 2017. Geneva: WHO; 2017.
-
- Pawlotsky JM, Negro F, Aghemo A, et al. EASL recommendations on treatment of hepatitis C 2018. J Hepatol 2018;69:461‐511. - PubMed
-
- World Health Organization . Global Health Sector Strategy on Viral Hepatitis, 2016‐2021 Towards Ending Viral Hepatitis. Geneva: WHO; 2016.
-
- Mahmud S, Kouyoumjian SP, Al Kanaani Z, et al. Individual‐level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. Ann Epidemiol 2018;28:452‐461. - PubMed
Publication types
LinkOut - more resources
Full Text Sources